Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Porro, Benedetta ^a   Eligini, Sonia ^a   Veglia, Fabrizio ^a   Lualdi, Alessandro ^a,b   Squellerio, Isabella ^a   Fiorelli, Susanna ^a   Giovannardi, Marta ^a   Chiorino, Elisa ^a   Dalla Cia, Alessia ^a   Crisci, Mauro ^a   Werba, José Pablo ^a   Tremoli, Elena ^a,b   Cavalca, Viviana ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BLOOD VESSELS; NITRIC OXIDE;

CORONARY ARTERY DISEASE; CORONARY STENOSIS; HEALTHY CONTROLS; IMMUNOFLUORESCENCE STAINING; METABOLIC PROFILES; PATHOLOGICAL CONDITIONS; SYNTHASE EXPRESSION; SYNTHETIC PATHWAYS;

OXIDATIVE STRESS;

ARGININE; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANTAGONISTS AND INHIBITORS; CORONARY ARTERY DISEASE; ENZYMOLOGY; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MICROVASCULAR ANGINA; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; TANDEM MASS SPECTROMETRY;

ADULT; AGED; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERY DISEASE; ERYTHROCYTES; FEMALE; GLUTATHIONE; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY;

EID: 84901299648     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/726539     Document Type: Article

References (51)

1. Moncada S., Palmer R. M. J., Higgs E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991 43 2 109 142 2-s2.0-0025883342
2. Radomski M. W., Palmer R. M. J., Moncada S., Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. The Lancet 1987 2 8567 1057 1058 2-s2.0-0023200487 (Pubitemid 17154788)
3. Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., Balzer J., Zotz R. B., Scharf R. E., Willers R., Schechter A. N., Feelisch M., Kelm M., Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radical Biology and Medicine 2006 40 2 295 302 2-s2.0-30344474311 10.1016/j.freeradbiomed.2005.08.025 (Pubitemid 43069353)
4. Rassaf T., Heiss C., Hendgen-Cotta U., Balzer J., Matern S., Kleinbongard P., Lee A., Lauer T., Kelm M., Plasma nitrite reserve and endothelial function in the human forearm circulation. Free Radical Biology and Medicine 2006 41 2 295 301 2-s2.0-33745253406 10.1016/j.freeradbiomed.2006.04.006 (Pubitemid 43928502)
5. Heiss C., Lauer T., Dejam A., Kleinbongard P., Hamada S., Rassaf T., Matern S., Feelisch M., Kelm M., Plasma nitroso compounds are decreased in patients with endothelial dysfunction. Journal of the American College of Cardiology 2006 47 3 573 579 2-s2.0-31644440884 10.1016/j.jacc.2005.06.089 (Pubitemid 43170846)
6. Morris S. M. Jr., Arginine metabolism in vascular biology and disease. Vascular Medicine 2005 10 supplement 1 S83 S87 2-s2.0-31344464146 10.1191/1358863x05vm601oa (Pubitemid 43137271)
7. Caplin B., Leiper J., Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 1343 1353 2-s2.0-84858986332 10.1161/ATVBAHA.112.247726
8. Wang Z., Tang W. H. W., Cho L., Brennan D. M., Hazen S. L., Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 9 1383 1391 2-s2.0-69849106418 10.1161/ATVBAHA.109.185645
9. Cortese-Krott M. M., Rodriguez-Mateos A., Sansone R., Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood 2012 120 20 4229 4237 10.1182/blood-2012-07-442277
10. Eligini S., Porro B., Lualdi A., Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease. PLoS ONE 2013 8 e66945
11. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., Kumara I., Gharini P., Kabanova S., Özüyaman B., Schnürch H.-G., Gödecke A., Weber A.-A., Robenek M., Robenek H., Bloch W., Rösen P., Kelm M., Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006 107 7 2943 2951 2-s2.0-33645532445 10.1182/blood-2005-10-3992
12. Wood K. C., Cortese-Krott M. M., Kovacic J. C., Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 33 1861 1871
13. Omodeo-Salè F., Cortelezzi L., Vommaro Z., Scaccabarozzi D., Dondorp A. M., Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme. American Journal of Physiology. Cell Physiology 2010 299 1 C148 C154 2-s2.0-77953786118 10.1152/ajpcell.00405.2009
14. Yokoro M., Suzuki M., Murota K., Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes. Bioscience, Biotechnology, and Biochemistry 2012 76 7 1334 1342
15. Kim P. S., Iyer R. K., Lu K. V., Yu H., Karimi A., Kern R. M., Tai D. K., Cederbaum S. D., Grody W. W., Expression of the liver form of arginase in erythrocytes. Molecular Genetics and Metabolism 2002 76 2 100 110 2-s2.0-0036020220 10.1016/S1096-7192(02)00034-3 (Pubitemid 34757133)
16. Jenkinson C. P., Grody W. W., Cederbaum S. D., Comparative properties of arginases. Comparative Biochemistry and Physiology B, Biochemistry and Molecular Biology 1996 114 1 107 132 2-s2.0-0030018043 10.1016/0305-0491(95)02138-8 (Pubitemid 26234050)
17. Yang J., Gonon A. T., Sjoquist P. O., Lundberg J. O., Pernow J., Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proceedings of the National Academy of Sciences of the United States of America 2013 110 15049 15054
18. Ryoo S., Gupta G., Benjo A., Lim H. K., Camara A., Sikka G., Lim H. K., Sohi J., Santhanam L., Soucy K., Tuday E., Baraban E., Ilies M., Gerstenblith G., Nyhan D., Shoukas A., Christianson D. W., Alp N. J., Champion H. C., Huso D., Berkowitz D. E., Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circulation Research 2008 102 8 923 932 2-s2.0-42549088600 10.1161/CIRCRESAHA.107.169573 (Pubitemid 351591553)
19. Jung C., Gonon A. T., Sjöquist P.-O., Lundberg J. O., Pernow J., Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovascular Research 2010 85 1 147 154 2-s2.0-72049107764 10.1093/cvr/cvp303
20. Zhang C., Hein T. W., Wang W., Miller M. W., Fossum T. W., McDonald M. M., Humphrey J. D., Kuo L., Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004 44 6 935 943 2-s2.0-9644282852 10.1161/01.HYP.0000146907.82869.f2 (Pubitemid 39577425)
21. White A. R., Ryoo S., Li D., Champion H. C., Steppan J., Wang D., Nyhan D., Shoukas A. A., Hare J. M., Berkowitz D. E., Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 2006 47 2 245 251 2-s2.0-31944447852 10.1161/01.HYP.0000198543.34502.d7 (Pubitemid 43189770)
22. Proudfit W. L., Shirey E. K., Sones F. M. Jr., Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients. Circulation 1966 33 6 901 910 2-s2.0-0013918394
23. Kemp H. G., Kronmal R. A., Vlietstra R. E., Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. Journal of the American College of Cardiology 1986 7 3 479 483 2-s2.0-0022648326 (Pubitemid 16164373)
24. Sharaf B. L., Pepine C. J., Kerensky R. A., Reis S. E., Reichek N., Rogers W. J., Sopko G., Kelsey S. F., Holubkov R., Olson M., Miele N. J., Williams D. O., Merz C. N. B., Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory). The American Journal of Cardiology 2001 87 8 937 941 2-s2.0-0035871536 10.1016/S0002-9149(01)01424-2 (Pubitemid 32299974)
25. Lanza G. A., Crea F., Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010 121 21 2317 2325 2-s2.0-77953218652 10.1161/CIRCULATIONAHA.109.900191
26. Cosín-Sales J., Pizzi C., Brown S., Kaski J. C., C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. Journal of the American College of Cardiology 2003 41 9 1468 1474 2-s2.0-0038747054 10.1016/S0735-1097(03)00243-2 (Pubitemid 36543361)
27. Egashira K., Inou T., Hirooka Y., Yamada A., Urabe Y., Takeshita A., Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. The New England Journal of Medicine 1993 328 23 1659 1664 2-s2.0-0027286628 10.1056/NEJM199306103282302 (Pubitemid 23157347)
28. Joannides R., Haefeli W. E., Linder L., Richard V., Bakkali E. H., Thuillez C., Luscher T. F., Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995 91 5 1314 1319 2-s2.0-0028957394
29. Kaski J. C., Rosano G. M. C., Collins P., Nihoyannopoulos P., Maseri A., Poole-Wilson P. A., Cardiac syndrome X: clinical characteristics and left ventricular function long-term follow-up study. Journal of the American College of Cardiology 1995 25 4 807 814 2-s2.0-0028946396 10.1016/0735-1097(94)00507-M
30. Murakami H., Urabe K., Nishimura M., Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X. Journal of the American College of Cardiology 1998 32 5 1287 1294 2-s2.0-0032211111 10.1016/S0735-1097(98)00402-1 (Pubitemid 28522385)
31. Özüyaman B., Grau M., Kelm M., Merx M. W., Kleinbongard P., RBC NOS: regulatory mechanisms and therapeutic aspects. Trends in Molecular Medicine 2008 14 7 314 322 2-s2.0-46049096535 10.1016/j.molmed.2008.05.002
32. Keymel S., Heiss C., Kleinbongard P., Kelm M., Lauer T., Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus. Hormone and Metabolic Research 2011 43 11 760 765 2-s2.0-80054853741 10.1055/s-0031-1286325
33. Horn P., Cortese-Krott M. M., Keymel S., Kumara I., Burghoff S., Schrader J., Kelm M., Kleinbongard P., Nitric oxide influences red blood cell velocity independently of changes in the vascular tone. Free Radical Research 2011 45 6 653 661 2-s2.0-79959421527 10.3109/10715762.2011.574288
34. Teichert A.-M., Miller T. L., Tai S. C., Wang Y., Bei X., Robb G. B., Phillips M. J., Marsden P. A., In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. American Journal of Physiology-Heart and Circulatory Physiology 2000 278 4 H1352 H1361 2-s2.0-0034097691 (Pubitemid 30235515)
35. Kleinbongard P., Keymel S., Kelm M., New functional aspects of the L-arginine-nitric oxide metabolism within the circulating blood. Thrombosis and Haemostasis 2007 98 5 970 974 2-s2.0-36048998921 10.1160/TH07-04-0305 (Pubitemid 350091124)
36. Demirkol S., Balta S., Celik T., Assessment of the relationship between red cell distribution width and cardiac syndrome X. Kardiologia Polska 2013 71 480 484
37. Chen J.-W., Hsu N.-W., Wu T.-C., Lin S.-J., Chang M.-S., Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. American Journal of Cardiology 2002 90 9 974 982 2-s2.0-0036828019 10.1016/S0002-9149(02)02664-4 (Pubitemid 35238049)
38. Piatti P., Fragasso G., Monti L. D., Setola E., Lucotti P., Fermo I., Paroni R., Galluccio E., Pozza G., Chierchia S., Margonato A., Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003 107 3 429 436 2-s2.0-0037469213 10.1161/01.CIR.0000046489.24563.79 (Pubitemid 36158045)
39. Squellerio I., Tremoli E., Cavalca V., Quantification of arginine and its metabolites in human erythrocytes using liquid chromatography-tandem mass spectrometry. Analytical Biochemistry 2011 412 1 108 110 2-s2.0-79952450444 10.1016/j.ab.2011.01.018
40. Morris C. R., Kato G. J., Poljakovic M., Wang X., Blackwelder W. C., Sachdev V., Hazen S. L., Vichinsky E. P., Morris S. M. Jr., Gladwin M. T., Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Journal of the American Medical Association 2005 294 1 81 90 2-s2.0-21444441271 10.1001/jama.294.1.81 (Pubitemid 41002842)
41. Sourij H., Meinitzer A., Pilz S., Grammer T. B., Winkelmann B. R., Boehm B. O., März W., Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis 2011 218 1 220 225 2-s2.0-80052273417 10.1016/j.atherosclerosis. 2011.04.041
42. Squellerio I., Caruso D., Porro B., Veglia F., Tremoli E., Cavalca V., Direct glutathione quantification in human blood by LC-MS/MS: comparison with HPLC with electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis 2012 71 111 118
43. Veglia F., Cighetti G., de Franceschi M., Zingaro L., Boccotti L., Tremoli E., Cavalca V., Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 2006 11 6 562 573 2-s2.0-33750338702 10.1080/13547500600898623 (Pubitemid 44614827)
44. Lauer T., Kleinbongard P., Rath J., Schulz R., Kelm M., Rassaf T., L-Arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow. Journal of Internal Medicine 2008 264 3 237 244 2-s2.0-49349090283 10.1111/j.1365-2796.2008.01943.x
45. Shemyakin A., Kovamees O., Rafnsson A., Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 2012 126 2943 2950
46. Spector E. B., Rice S. C. H., Cederbaum S. D., Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients. Pediatric Research 1983 17 12 941 944 2-s2.0-0021013595 (Pubitemid 14209281)
47. Schnorr O., Brossette T., Momma T. Y., Kleinbongard P., Keen C. L., Schroeter H., Sies H., Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Archives of Biochemistry and Biophysics 2008 476 2 211 215 2-s2.0-46049084076 10.1016/j.abb.2008.02.040
48. Maseri A., Crea F., Kaski J. C., Crake T., Mechanisms of angina pectoris in syndrome X. Journal of the American College of Cardiology 1991 17 2 499 506 2-s2.0-0025730754
49. Setoguchi S., Mohri M., Shimokawa H., Takeshita A., Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease. Journal of the American College of Cardiology 2001 38 2 493 498 2-s2.0-0034890205 10.1016/S0735-1097(01)01382-1 (Pubitemid 32721779)
50. Dhawan S. S., Eshtehardi P., McDaniel M. C., Fike L. V., Jones D. P., Quyyumi A. A., Samady H., The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability. Atherosclerosis 2011 219 1 266 272 2-s2.0-80054993906 10.1016/j.atherosclerosis.2011.05.020
51. Rassaf T., Kleinbongard P., Kelm M., The L-arginine nitric oxide pathway: avenue for a multiple-level approach to assess vascular function. Biological Chemistry 2006 387 10-11 1347 1349 2-s2.0-33750625767 10.1515/BC.2006.168 (Pubitemid 44691413)